Determinants of cancer screenings participation in Queensland: a scoping review

Lui, Paraniala Silas C.; Singh, Kamal; Nguyen, Tam; Kurth, Brian; Phan, Thuc; Nelson, Ashleigh; Danisevska, Renata; De Ambrosis, Tony

doi:10.1071/hc23012

Cited by 3 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The treatment gap is a focus of Lillis' 18 study of prescribing data for the use of psychostimulants in the management of Attention deficit and hyperactivity disorder. Lui and colleagues 19 in their scoping review of determinants of cancer screening participation among target groups in Queensland explored reasons for non-attendance using a behavioural change model.…”

Section: Doing the 'Bread And Butter' Of General Practice Well In Unc...mentioning

confidence: 99%

Doing the ‘bread and butter’ of general practice well in uncertain times

Stokes,

Goodyear-Smith

2024

J. Prim. Health Care

View full text Add to dashboard Cite

Section: Doing the 'Bread And Butter' Of General Practice Well In Unc...mentioning

confidence: 99%

Doing the ‘bread and butter’ of general practice well in uncertain times

Stokes,

Goodyear-Smith

2024

J. Prim. Health Care

View full text Add to dashboard Cite

Global Disparities of Cancer and Its Projected Burden in 2050

Bizuayehu,

Ahmed,

Kibret

et al. 2024

JAMA Netw Open

View full text Add to dashboard Cite

ImportanceCancer prevention and care efforts have been challenged by the COVID-19 pandemic and armed conflicts, resulting in a decline in the global Human Development Index (HDI), particularly in low- and middle-income countries. These challenges and subsequent shifts in health care priorities underscore the need to continuously monitor cancer outcome disparities and statistics globally to ensure delivery of equitable and optimal cancer prevention and care in uncertain times.ObjectiveTo measure the global burden of 36 cancers in 2022 by sex, age, and geographic location and to project future trends by 2050.Design, Setting, and ParticipantsThis cross-sectional study used population-based data from 2022 in 185 countries and territories were obtained from the Global Cancer Observatory database. Data extraction and analysis were carried out in April 2024.Main Outcomes and MeasuresCounts, rates, prevalence, mortality to incidence ratios (MIRs), and demography-based projections were used to characterize current and future cancer burden.ResultsThis population-based study included 36 cancer types from 185 countries and territories. By 2050, 35.3 million cancer cases worldwide are expected, a 76.6% increase from the 2022 estimate of 20 million. Similarly, 18.5 million cancer deaths are projected by 2050, an 89.7% increase from the 2022 estimate of 9.7 million. Cancer cases and deaths are projected to nearly triple in low-HDI countries by 2050, compared to a moderate increase in very high–HDI countries (142.1% vs 41.7% for cancer cases and 146.1% vs 56.8% for cancer deaths). Males had a higher incidence and greater number of deaths in 2022 than females, with this disparity projected to widen by up to 16.0% in 2050. In 2022, the MIR for all cancers was 46.6%, with higher MIRs observed for pancreatic cancer (89.4%), among males (51.7%), among those aged 75 years or older (64.3%), in low-HDI countries (69.9%), and in the African region (67.2%).Conclusions and RelevanceIn this cross-sectional study based on data from 2022, cancer disparities were evident across HDI, geographic regions, age, and sex, with further widening projected by 2050. These findings suggest that strengthening access to and quality of health care, including universal health insurance coverage, is key to providing evidence-based cancer prevention, diagnostics, and care.

show abstract

Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimates

Bizuayehu,

Dadi,

Ahmed

et al. 2024

Cancer

View full text Add to dashboard Cite

BackgroundMen exhibit higher prevalence of modifiable risk factors, such as smoking and alcohol consumption, leading to greater cancer incidence and lower survival rates. Comprehensive evidence on global cancer burden among men, including disparities by age group and country, is sparse. To address this, the authors analyzed 30 cancer types among men in 2022, with projections estimated for 2050.MethodsThe 2022 GLOBOCAN estimates were used to describe cancer statistics for men in 185 countries/territories worldwide. Mortality‐to‐incidence ratios (MIRs) were calculated by dividing age‐standardized mortality rates by incidence rates.ResultsIn 2022, a high MIR (indicating poor survival) was observed among older men (aged 65 years and older; 61%) for rare cancer types (pancreatic cancer, 91%) and in countries with low a Human Development Index (HDI; 74%). Between 2022 and 2050, cancer cases are projected to increase from 10.3 million to 19 million (≥84%). Deaths are projected to increase from 5.4 million to 10.5 million (≥93%), with a greater than two‐fold increase among men aged 65 years and older (≥117%) and for low‐HDI and medium‐HDI countries/territories (≥160%). Cancer cases and deaths are projected to increase among working‐age groups (≥39%) and very‐high‐HDI countries/territories (≥50%).ConclusionsSubstantial disparities in cancer cases and deaths were observed among men in 2022, and these are projected to widen by 2050. Strengthening health infrastructure, enhancing workforce quality and access, fostering national and international collaborations, and promoting universal health coverage are crucial to reducing cancer disparities and ensuring cancer equity among men globally.

show abstract

Determinants of cancer screenings participation in Queensland: a scoping review

Cited by 3 publications

References 36 publications

Doing the ‘bread and butter’ of general practice well in uncertain times

Doing the ‘bread and butter’ of general practice well in uncertain times

Global Disparities of Cancer and Its Projected Burden in 2050

Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimates

Contact Info

Product

Resources

About